Omeros (OMER) Selling, General & Administrative (2010 - 2026)

Omeros (OMER) Selling, General & Administrative (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -10.08 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 2.17 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 555.10 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 493.70 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 647.70 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 17.02 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -355.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 101.25 Mn
10 Omeros 707.67 Mn 707.67 Mn 9.31 Mn 13.37 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 13.37 Mn
Dec 31, 2025 9.64 Mn
Sep 30, 2025 10.40 Mn
Jun 30, 2025 10.35 Mn
Mar 31, 2025 11.12 Mn
Dec 31, 2024 10.04 Mn
Sep 30, 2024 11.32 Mn
Jun 30, 2024 13.81 Mn
Mar 31, 2024 12.26 Mn
Dec 31, 2023 10.88 Mn
Sep 30, 2023 16.42 Mn
Jun 30, 2023 11.26 Mn
Mar 31, 2023 11.10 Mn
Dec 31, 2022 13.59 Mn
Sep 30, 2022 12.20 Mn
Jun 30, 2022 13.92 Mn
Mar 31, 2022 10.96 Mn
Dec 31, 2021 12.56 Mn
Sep 30, 2021 14.01 Mn
Jun 30, 2021 15.48 Mn